Carol shared her latest research findings on the role of ANXA3 in mediating sorafenib resistance in HCC at the annual SKLLR Symposium held on Nov 11 2017. Stephanie also shared the team’s latest research work on PRMT6 in regulating liver cancer stemness and glucose metabolic rewiring.
Stephanie Ma co-chaired one of the sessions at the Keystone Symposium on Regenerative Biology and Applications: Cell Differentiation, Tissue Organization and Biomedical Engineering, held in Hong Kong from October 15-19 2017.
Please see link below for full program:
http://www.keystonesymposia.org/17T3
Another new academic year! We welcome Jane and Michael who just started their MPhil programs with us as of Sept 1 2017. Best of luck with your studies ahead!
And thank you team for the birthday cake and lunch!
Our work on the role of FSTL1 in promoting metastasis and chemoresistance in ESCC via NFkB-BMP signaling crosstalk published in the November 2017 issue of Cancer Research. Congratulations to Marco, Johnson and the team!
http://cancerres.aacrjournals.org/content/early/2017/09/07/0008-5472.CAN-17-1411
Stephanie shared the team’s latest work on PRMT6 in HCC at the State Key Laboratory of Digestive Disease Monthly Research Meeting in CUHK on 31 August 2017.
Our work on the role of TP53INP1 in HCC metastasis published in the September 2017 issue of Cancer Research. Congratulations to Johnson!
The Croucher Summer Course in Cancer Biology took place in HK from Aug 7-11 2017, where Stephanie had the opportunity to share the team’s latest research work on PRMT6.
Congratulation to Ben (BBMS FYP student) and Dag (Biochem intern) on completing their studies in our lab and for their outstanding performance at their final oral presentations. Good job!
Our anti-human ANXA3 monoclonal antibody is now available at Sigma-Aldrich. Validated applications include IHC (paraffin), Western Blotting and Neutralization.
Goodbye Jack. Thank you for your contribution to our lab. Wishing you all the best in your new endeavors at Yale! Stay in touch!
SMA Lab 